Open Access Peer-Reviewed
Editorial

Causes of interruption of bevacizumab therapy in age-related macular degeneration

Causas de interrupção do tratamento com bevacizumab em degeneração macular relacionada à idade

Renata Portella Nunes1; Mário Junqueira Nóbrega2; Fernando José De Novelli2; Samuel Ângelo Coral2; Thais Bacha Berti2; Marina Maria Drumm Missen3; Marina Canuto Correa3

DOI: 10.1590/S0004-27492010000200009

Altmetric

No results

Dimension

Demographic

*The geographic data may vary due to user access settings.

Dimension

© 2024 - All rights reserved - Conselho Brasileiro de Oftalmologia